ArticleEuropean journal of nuclear medicine and molecular imaging2021
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 95 papers, 10 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies
Who cites it
95 citing papers in PubMed, 10 syntheses or guidelines pooled it, 174 citations in OpenAlex.
- Comparative diagnostic performance of [68 Ga]Ga-FAPI PET/CT and [18 F]FDGPET/CT in biliary tract cancers: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2025Pooled it
- Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging.Systematic reviews · 2025Pooled it
- Diagnostic Performance of Radiolabelled FAPI Versus [International journal of molecular sciences · 2025Pooled it
- Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review.International journal of molecular sciences · 2023Pooled it
- Comparison ofFrontiers in oncology · 2023Pooled it
- Head-to-head comparison ofFrontiers in oncology · 2023Pooled it
- A systematic review of [Frontiers in oncology · 2022Pooled it
- Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?Contrast media & molecular imaging · 2022Pooled it
- State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021Pooled it
- Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [International journal of molecular sciences · 2021Pooled it
- Assessment of liver fibrosis and tumor burden in hepatocellular carcinoma using [European journal of nuclear medicine and molecular imaging · 2026Trial
- Fibroblast activation protein-targeted PET/CT withEuropean journal of nuclear medicine and molecular imaging · 2025Trial
- Diagnostic performance of [European journal of nuclear medicine and molecular imaging · 2025Trial
- Head-to-head comparison ofAnnals of nuclear medicine · 2025Trial
- Head-to-head study of [BMC cancer · 2024Trial
- Comparison of lesion detection rates between FAPI PET/CT andJapanese journal of radiology · 2026Article
- Localization of an ectopic hepatic parathyroid adenoma with [European journal of nuclear medicine and molecular imaging · 2026Article
- Diagnostic value of [European journal of nuclear medicine and molecular imaging · 2026Article
- Diagnostic Value ofMolecular imaging and radionuclide therapy · 2026Article
- [Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
35 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 1 institution in 1 country.
Funding
Abstract
purposeThis study aimed to evaluate the potential utility of [
methodsWe performed a single-center post hoc retrospective analysis of data obtained from a prospective parent study (NCT04416165). This study included 34 patients diagnosed with or suspected hepatic lesions who underwent concomitant [
resultsAmong the 34 patients, 20, 12, and 2 patients presented with hepatocellular carcinomas, intrahepatic cholangiocarcinomas, and benign hepatic nodules, respectively. The sensitivities of CE-CT, MRI, [
conclusionsOur findings indicate that the sensitivity of [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.